Purdue David Ryan 4

What Happened David Purdue, Senior Vice President and Controller at AbbVie (ABBV), reported a sale of 5,230 shares on March 4, 2026. The shares were disposed at $233.56 each for a total value of $1,221,519. The Form 4 lists the transaction as an open-market or private sale (code S).

Key Details

• Transaction date: March 4, 2026; reported on Form 4 filed March 6, 2026 (appears within the standard two-business-day reporting window).
• Price and amount: 5,230 shares at $233.56 per share; proceeds ≈ $1,221,519.
• Shares owned after transaction: not specified in the excerpt provided.
• Footnote: F1 notes the balance in the AbbVie Savings Program as of Feb 20, 2026; that balance includes shares from dividend reinvestment.
• Filing timeliness: No late-filing flag present in the supplied data.

Context This was a sale (disposition), which is a common insider action and does not by itself indicate the insider's view of the company. Purchases generally carry more direct informational weight for investors; sales may reflect routine portfolio management, tax or savings-plan needs, or other personal reasons.